New

AbbVie

The AI engine Fit Assessment

Beta

AbbVie engages in pharmaceutical R&D, development and operations across multiple therapeutic areas, demonstrating pharma-tech capabilities and technology-enabled research and manufacturing.

Blurb

AbbVie is a biopharmaceutical company focused on immunology, oncology, neuroscience, virology, and aesthetics.

HQ Location

North Chicago (United States)

Founded

2013

Employees

10000+

Total funding raised

$23.00B

Funding Status

Post-IPO Debt, $8.00B, February 26, 2026

AbbVie is a biopharmaceutical company that develops pharmaceuticals and medical devices. The company provides products and services to therapeutic areas including immunology, oncology, neuroscience, eye care,virology, women's health, and gastroenterology advancing treatments across various therapeutic areas.